According to a new report published by Allied Market Research, titled, โMacular Degeneration Treatment Market: Global Opportunity Analysis and Industry Forecast, 2020-2027โ Macular Degeneration is one of the causes of vision loss. Macular Degeneration is triggered by the deterioration of the central portion of the retina, the inside back layer of the eye that records the images one sees and sends them via the optic nerve from the eye to the brain. The other part of the eye includes, the retinaโs central portion, called as the macula, which is responsible for focusing central vision in the eye, and it controls our ability to drive a car, read, recognize faces or colors, and see objects in fine detail. There are three stages of AMD, which are Early AMD, wherein yellow deposits beneath retina are observed and can only be diagnosed during regular eye check-up. The second stage includes partial loss of the vision but sometimes noticeable symptoms may not be present. The last stage includes complete vision loss.
๐๐จ๐ฐ๐ง๐ฅ๐จ๐๐ ๐๐๐ ๐๐จ๐ฎ๐๐ก๐๐ซ: https://www.alliedmarketresearch.com/request-sample/11581
COVID-19 Scenario Analysis
Pharmaceutical and biotechnological companies have joined hands with governments around the globe to combat with the COVID-19 outbreak, for assisting in the development of various vaccines to ensure appropriate alternatives for medicines supply chain challenges. The estimates suggest that there are about 115 vaccine candidates and about 155 molecules, which are in the R&D pipeline. Due to the demand for vaccine and treatment drugs for COVID-19, the pharmaceutical and biotechnology industry is hence anticipated to witness a significant growth for the newly developed drugs for the managements of the COVID-19 in the future. The current scenario has brought halt in the massive production of the medications used for macular degeneration treatment and also has broadly affected the supply of the medications, which is probing challenges for the major market players. However, the growing concern to lead healthy life has emerged due to the pandemic and hence, would propel the growth of this industry in the coming years.
The growth in the number of individuals who are susceptible to have Macular Degeneration is expected to help the market gain maximum shares in the coming years. According to the statistics given by the Bright Focus Foundation, about 11 million people in the U.S. have some form of age-related macular degeneration. Additionally, the number is expected to double to nearly 22 million by 2050 according to the growth rate.
Furthermore, the total number of people living with macular degeneration is anticipated to reach 196 million worldwide by 2020 and rise to about 288 million by 2040. The foundation also stated that age is a prominent risk factor for age-related macular degeneration. The risk of getting advanced age-related macular degeneration upsurges from 2% for those ages 50-59, to approximately 30% for those over the age of 75.
๐๐ฎ๐ซ๐๐ก๐๐ฌ๐ ๐๐ง๐ช๐ฎ๐ข๐ซ๐ฒ: https://www.alliedmarketresearch.com/purchase-enquiry/11581
The key players profiled in this report include Novartis AG, F. Hoffmann-La Roche AG, Bausch Health Companies Inc., Regeneron, Ellex, REGENXBIO Inc., Aerie Pharmaceutical Inc., Panoptica, and Pfizer Inc.
๐๐๐ฒ ๐๐๐ง๐๐๐ข๐ญ๐ฌ:
- This study presents the analytical depiction of the global macular degeneration treatment industry along with the current trends and future estimations to determine the imminent investment pockets.
- The report presents information related to key drivers, restraints, and opportunities along with detailed analysis of the global macular degeneration treatment market share.
- The current market is quantitatively analyzed from 2020 to 2027 to highlight the global Macular Degeneration Treatment market growth scenario.
- Porterโs five forces analysis illustrates the potency of buyers & suppliers in the macular degeneration treatment market.
- The report provides a detailed global macular degeneration treatment market analysis based on competitive intensity and how the competition will take shape in coming years.
๐๐๐ช๐ฎ๐๐ฌ๐ญ ๐๐ฎ๐ฌ๐ญ๐จ๐ฆ๐ข๐ณ๐๐ญ๐ข๐จ๐ง: https://www.alliedmarketresearch.com/request-for-customization/11581
๐๐ญ๐ก๐๐ซ ๐๐ซ๐๐ง๐๐ข๐ง๐ ๐๐๐ฉ๐จ๐ซ๐ญ๐ฌ:
North America and Europe Menstrual Cup Market: https://www.alliedmarketresearch.com/north-america-and-europe-menstrual-cup-market-A06126
Surgical Robotic System Market: https://www.alliedmarketresearch.com/surgical-robotic-systems-market-A06827
Surgical Drains Market: https://www.alliedmarketresearch.com/wound-drainage-surgical-drains-market-A07517
๐๐๐จ๐ฎ๐ญ ๐๐ฌ:
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP, based in Portland, Oregon. AMR provides global enterprises as well as medium and small businesses with unmatched quality of โMarket Research Reportsโ and โBusiness Intelligence Solutions.โ AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
AMR introduces its online premium subscription-based library Avenue, designed specifically to offer cost-effective, one-stop solution for enterprises, investors, and universities. With Avenue, subscribers can avail an entire repository of reports on more than 2,000 niche industries and more than 12,000 company profiles. Moreover, users can get an online access to quantitative and qualitative data in PDF and Excel formats along with analyst support, customization, and updated versions of reports.
Contact:
David Correa
5933 NE Win Sivers Drive
205, Portland, OR 97220
United States
Toll Free: 1-800-792-5285
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1-855-550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com